UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

ESC Heart Failure, 2020-10, Vol.7 (5), p.2494-2507

2020

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

PloS one, 2015-08, Vol.10 (8), p.e0135427

2015

Volltextzugriff (PDF)

Increased plasma myostatin in heart failure

European journal of heart failure, 2011-07, Vol.13 (7), p.734-736

2011

Volltextzugriff (PDF)

The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla ( Emblica officinalis ), walnut ( Juglans regia ), olive ( Olea europaea ) and red yeast rice ( Monascus purpureus ) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia

Frontiers in pharmacology, 2023-11, Vol.14, p.1280234-1280234

2023

Volltextzugriff (PDF)

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Lipids in health and disease, 2017-09, Vol.16 (1), p.171-171, Article 171

2017

Volltextzugriff (PDF)

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Lipids in health and disease, 2012-10, Vol.11 (1), p.132-132, Article 132

2012

Volltextzugriff (PDF)

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

Peptides (New York, N.Y. : 1980), 2012-10, Vol.37 (2), p.258-262

2012

Volltextzugriff (PDF)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

Cardiovascular diabetology, 2011-02, Vol.10 (1), p.20-20

2011

Volltextzugriff (PDF)

Potential synergistic antihyperglycemic effects of co-supplemental Amla and Olive extracts in hyperlipidemic adults with prediabetes and type 2 diabetes: results from a real-life clinical study

Frontiers in nutrition (Lausanne), 2024-10, Vol.11, p.1462292

2024

Volltextzugriff (PDF)

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

The Annals of thoracic surgery, 2016-06, Vol.101 (6), p.2176-2184

2016

Volltextzugriff (PDF)

Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failure

Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2021-12, Vol.2 (4), p.541-544

2021

Volltextzugriff (PDF)

Elevation of plasma oncostatin M in heart failure

Future cardiology, 2017-05, Vol.13 (3), p.219-227

2017

Volltextzugriff (PDF)

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Cardiovascular diabetology, 2010-12, Vol.9 (1), p.88-88

2010

Volltextzugriff (PDF)

Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes

Diabetes & metabolism, 2009-12, Vol.35 (6), p.484-489

2009

Volltextzugriff (PDF)

Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance

JACC. Cardiovascular imaging, 2019-12, Vol.12 (12), p.2373-2385

2019

Volltextzugriff (PDF)

Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes

Journal of diabetes and its complications, 2019-11, Vol.33 (11), p.107413-107413, Article 107413

2019

Volltextzugriff (PDF)

Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction

International journal of cardiology, 2014-03, Vol.172 (1), p.e250-e252

2014

Volltextzugriff (PDF)

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy

Journal of the American College of Cardiology, 2012-02, Vol.59 (9), p.825-835

2012

Volltextzugriff (PDF)

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study

JACC. Cardiovascular imaging, 2015-08, Vol.8 (8), p.934-946

2015

Volltextzugriff (PDF)

Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction

International journal of cardiology, 2017-12, Vol.248, p.270-273

2017

Volltextzugriff (PDF)

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy

JACC. Cardiovascular imaging, 2015-08, Vol.8 (8), p.934-946

2015

Volltextzugriff (PDF)

Lipoprotein(a) Levels Are Twice as High in Left-Handed T2DM Patients

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Circulation. Cardiovascular imaging, 2021-01, Vol.14 (1), p.e011680-e011680

2021

Volltextzugriff (PDF)

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients

Clinical biochemistry, 2018-11, Vol.61, p.47-49

2018

Volltextzugriff (PDF)

Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines

Acta Cardiologica, 2021-07, Vol.76 (4), p.375-383

2021

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(161)
Webseiten
(1)

Sprache

Englisch
(162)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

Increased plasma myostatin in heart failure

The mixed benefit of low lipoprotein(a) in type 2 diabetes

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

Potential synergistic antihyperglycemic effects of co-supplemental Amla and Olive extracts in hyperlipidemic adults with prediabetes and type 2 diabetes: results from a real-life clinical study

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failure

Elevation of plasma oncostatin M in heart failure

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes

Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance

Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes

Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study

Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy

Lipoprotein(a) Levels Are Twice as High in Left-Handed T2DM Patients

Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients

Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines

Suchergebnisse filtern